Beta-adrenergic antagonist compounds and derivatives of beta-adrenergic antagonists
申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:EP0117089A1
公开(公告)日:1984-08-29
Molecular structures of β-adrenergic antagonists are modified to produce biologically active compounds. The β-antagonists are modified to form molecules of the general structure:
wherein R is most generally R"-OCH2-, and in some instances is R"-, and R" = an aryl or substituted aryl moiety;
R' = -H, -CH3, or a short chain alkyl moiety; and Y = -OH, or more usually, -OAX or -NHAX, where
A = an alkyl, aryl, or aralkyl moiety, and
X = a terminal grouping, such as -CH3, -CF3 or -(CH2)nCOOH; or AX may be a carrier moiety consisting of a defined peptide or protein.
对β-肾上腺素能拮抗剂的分子结构进行改造,以产生具有生物活性的化合物。对 β-肾上腺素能拮抗剂进行修饰,形成具有一般结构的分子:
其中 R 一般为 R"-OCH2-,在某些情况下为 R"-,R" = 芳基或取代芳基;
R' = -H、-CH3 或短链烷基;以及 Y = -OH,或更常见的 -OAX 或 -NHAX,其中
A = 烷基、芳基或芳烷基分子,以及
X = 末端基团,如-CH3、-CF3 或-(CH2)nCOOH;或者 AX 可以是由定义的肽或蛋白质组成的载体分子。